Correlation of Circulating Glucocorticoid-Induced TNFR-Related Protein Ligand Levels with Disease Activity in Patients with Systemic Lupus Erythematosus

Table 1

Characteristics of SLE patients and the control subjects.

	SLE (𝑛=58)	Control (𝑛=30)
Age (years)	30.6 ± 11.5	29.7 ± 6.8
Sex (female/male)	54/4	27/3
Disease duration (months)	24.9 ± 40.9	—
Alopecia 𝑛 (%)	13 (22.4)	—
Rash 𝑛 (%)	34 (58.6)	—
Arthritis 𝑛 (%)	11 (19.0)	—
Fever 𝑛 (%)	15 (25.9)	—
Pleuritis 𝑛 (%)	9 (15.5)	—
Anemia 𝑛 (%)	28 (48.3)	—
Leukopenia 𝑛 (%)	23 (39.7)	—
Thrombocytopenia 𝑛 (%)	5 (8.6)	—
Current renal disease 𝑛 (%)	33 (56.9)	—
Vasculitis 𝑛 (%)	24 (41.4)	—
Anti-ds-DNA 𝑛 (%)	34 (58.6)	—
Low C3 𝑛 (%)	35 (60.3)	—
Low C4 𝑛 (%)	30 (51.7)	—
ESR 𝑛 (%)	41 (70.7)	—
CRP 𝑛 (%)	19 (32.7)	—
24-hour urine protein 𝑛 (%)	28 (48.3)	—
SLEDAI	0 to 34; (22.5 ± 12.02)	—

Abbreviations—SLE: systemic lupus erythematosus; SLEDAI: systemic lupus erythematosus disease activity index; C3: complement 3; C4: complement 4; CRP: C-reactive protein; anti-ds-DNA: anti-double stranded DNA antibody; ESR: erythrocyte sedimentation rate; SLE: systemic lupus erythematosus; values are expressed as mean ± standard deviation.